“…Ethylenediamine (EDA) causes a marked depression of neuronal activity when applied iontophoretically to central neurones (Anderson, Haas & Hosli, 1973;Phillis, 1977;Perkins & Stone, 1980; Perkins, Bowery, Hill & Stone, 1981) and this action can be antagonized by bicuculline (Forster, Lloyd, Morgan, Parker, Perkins & Stone, 1981;. EDA can also release [3H]-yaminobutyric acid (GABA) and inhibit [3H]-GABA uptake in rat brain slices (Forster et al, 1981;Lloyd, Perkins, Gaitonde & Stone, 1982a;Lloyd, Perkins & Stone, 1982b), depolarize the superior cervical ganglion with a pharmacological profile of action similar to GABA and displace [3H]-GABA, [3H]-muscimol, and [3H]-baclofen binding to rat synaptic membrane (Bowery, Hill, Hudson, Perkins & Stone, 1982). Taken collectively the evidence strongly suggests that EDA acts upon GABA receptors .…”